相关实验视频

Updated: Jul 15, 2025

Generation of a Novel Dendritic-cell Vaccine Using Melanoma and Squamous Cancer Stem Cells

Generation of a Novel Dendritic-cell Vaccine Using Melanoma and Squamous Cancer Stem Cells

Published on: January 6, 2014

质瘤的树突细胞疫苗:从长椅到床上的挑战

Ye Zheng¹, Xiaoyu Ma¹, Shouchang Feng¹

¹Department of Neurosurgery, Tongji Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan, China.

Frontiers in immunology

|October 2, 2023

概括

树突细胞疫苗 (DCV) 在治疗致命的脑癌质母细胞瘤 (GBM) 方面表现有前途. 这篇评论探讨了DCV.

科学领域:

神经瘤学神经瘤学
免疫学免疫学免疫学
癌症治疗癌症治疗

背景情况:

质母细胞瘤 (GBM) 是最恶性的脑瘤,标准治疗的结果很差.
GBM的"冷瘤"表型阻碍了有效的免疫疗法反应.
树突细胞 (DCs) 通过启动T细胞反应,对抗瘤免疫至关重要.

研究的目的:

审查树突细胞 (DCs) 在抗瘤免疫力对抗质母细胞瘤 (GBM) 的作用.
总结一下用于治疗GBM的树突细胞疫苗 (DCV) 的临床试验.
分析GBM治疗中DCV的挑战和未来方向.

主要方法:

在抗瘤免疫中树突细胞功能的文献综述.
对瘤微环境 (TME) 对DCs的抑制作用的分析.
过去和现在的临床试验的总结和批判性评估,涉及GBM的DCV.

主要成果:

DCs对于启动抗瘤免疫反应至关重要.
在GBM瘤微环境 (TME) 显著抑制DC功能.
现有的针对GBM的DCV临床试验面临着局限性和挑战.

结论:

DCV对GBM具有治疗潜力,但仍然存在重大障碍.
克服TME介导的免疫抑制是有效的DCV治疗的关键.
需要进一步的研究和创新策略来优化DCV用于GBM治疗.

关键词:

树突细胞的树突细胞.树突细胞疫苗树突细胞疫苗质瘤质瘤是一种质瘤微环境是一个微环境.免疫疗法免疫疗法

更多相关视频

Stereotactic Adoptive Transfer of Cytotoxic Immune Cells in Murine Models of Orthotopic Human Glioblastoma Multiforme Xenografts

Stereotactic Adoptive Transfer of Cytotoxic Immune Cells in Murine Models of Orthotopic Human Glioblastoma Multiforme Xenografts

Published on: September 1, 2018

Preparation of Tumor Antigen-loaded Mature Dendritic Cells for Immunotherapy

Preparation of Tumor Antigen-loaded Mature Dendritic Cells for Immunotherapy

Published on: August 1, 2013

相关概念视频

Cancer Vaccines

Cancer Vaccines

Cancer treatment vaccines are a rapidly evolving field that offers a promising approach to immunotherapy. Unlike traditional vaccines that prevent diseases, cancer treatment vaccines are designed to treat existing cancers by stimulating the immune system to recognize and attack cancer cells.
Cancer vaccines come in two categories: preventive (prophylactic) and treatment (active). Preventive vaccines, such as the Human Papillomavirus (HPV) vaccine, protect against viruses that cause certain...

Tumor Immunotherapy

Tumor Immunotherapy

Immunotherapy is a treatment that boosts or manipulates the immune system to fight diseases, including cancer. For instance, by stimulating an immune response through vaccinations against viruses that cause cancers, like hepatitis B virus and human papillomavirus, these diseases can be prevented. Nonetheless, some cancer cells can avoid the immune system due to their rapid mutation and division. The immune response to many cancers involves three phases: elimination, equilibrium, and escape.